| RS2037229663 |
CEP290
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2037232562 |
CCDC40
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia 15 |
| RS2037236648 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2037256715 |
RAX2
|
Health Risk |
Pathogenic |
— |
| RS2037262817 |
RAX2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 95, Retinitis pigmentosa 95 |
| RS2037268635 |
PIEZO2
|
Health Risk |
Likely pathogenic |
— |
| RS2037306370 |
PIBF1
|
Health Risk |
Pathogenic |
Joubert syndrome 33, Joubert syndrome 33 |
| RS2037326125 |
BUB1B
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS2037335667 |
PIEZO2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2037346846 |
BUB1B
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS2037350060 |
BUB1B
|
Health Risk |
Likely pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS2037363765 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2037378158 |
ARL6
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 3, Retinitis pigmentosa 55 |
| RS2037381055 |
ARL6
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2037388926 |
GREB1L
|
Health Risk |
Likely pathogenic |
Renal hypodysplasia/aplasia 3, Renal hypodysplasia/aplasia 3 |
| RS2037388948 |
GPR179
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 1E, Congenital stationary night blindness 1E |
| RS2037399601 |
MAPK8IP3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS2037410932 |
GPR179
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 1B, Congenital stationary night blindness 1B |
| RS2037415464 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2037417315 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2037428827 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2037428972 |
GREB1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal hypodysplasia/aplasia 3, Mayer-Rokitansky-Kuster-Hauser syndrome |
| RS2037432429 |
SHMT2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with cardiomyopathy, spasticity |
| RS2037437436 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2037451732 |
POLR3B
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism |
| RS2037451945 |
POLR3B
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, demyelinating |
| RS2037465152 |
SHMT2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with cardiomyopathy, spasticity |
| RS2037466762 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2037471500 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS2037477197 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2037478393 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2037480294 |
CEP290
|
Health Risk |
Likely pathogenic |
CEP290-related disorder, Leber congenital amaurosis 10 |
| RS2037480406 |
CEP290
|
Health Risk |
Likely pathogenic |
CEP290-related disorder, Joubert syndrome |
| RS2037488871 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome, Cowden syndrome 1 |
| RS2037490138 |
POLR3B
|
Health Risk |
Likely pathogenic |
— |
| RS2037491178 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2037491872 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2037492289 |
POLR3B
|
Health Risk |
Likely pathogenic |
— |
| RS2037495535 |
LOXHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS2037500230 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS2037501401 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2037525325 |
IFT43
|
Health Risk |
Likely pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2037540861 |
CCDC40
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2037541934 |
ARL6
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 55, Bardet-Biedl syndrome 3 |
| RS2037558268 |
NBEAL2
|
Health Risk |
Pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2037587680 |
BUB1B
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS2037617604 |
PET117
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 19 |
| RS2037617658 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2037622753 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2037623971 |
GREB1L
|
Health Risk |
Likely pathogenic |
Renal hypodysplasia/aplasia 3, Renal hypodysplasia/aplasia 3 |
| RS2037655865 |
COL18A1
|
Health Risk |
Likely pathogenic |
— |
| RS2037658180 |
GLDN
|
Health Risk |
Likely pathogenic |
Lethal congenital contracture syndrome 11, Lethal congenital contracture syndrome 11 |
| RS2037658254 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2037660713 |
GNAO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with involuntary movements, Inborn genetic diseases |
| RS2037679829 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2037680211 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Usher syndrome type 2A |
| RS2037681648 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2037682180 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Usher syndrome |
| RS2037684112 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2037684727 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2037686445 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Retinitis pigmentosa 39 |
| RS2037686992 |
BUB1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Mosaic variegated aneuploidy syndrome 1 |
| RS2037693105 |
BUB1B
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS2037693846 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2037697286 |
POLR3B
|
Health Risk |
Pathogenic |
— |
| RS2037702385 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2037704254 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2037707020 |
DHX30
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder with severe motor impairment and absent language |
| RS2037724743 |
GNAO1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2037724762 |
GNAO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2037726277 |
BUB1B
|
Health Risk |
Likely pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS2037728032 |
BUB1B
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS2037743862 |
GNAO1
|
Health Risk |
Likely pathogenic |
Movement disorder, Movement disorder |
| RS2037750426 |
CIC
|
Health Risk |
Likely pathogenic |
— |
| RS2037751886 |
ARL6
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2037752645 |
ARL6
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2037753806 |
CIC
|
Health Risk |
Likely pathogenic |
CIC-related neurodevelopmental disorders, Intellectual disability |
| RS2037760415 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive retinitis pigmentosa, Usher syndrome |
| RS2037760521 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome type 2A |
| RS2037761675 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2037761776 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2037762589 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2037778050 |
PLCB4
|
Health Risk |
Likely pathogenic |
Auriculocondylar syndrome 2, Auriculocondylar syndrome 2 |
| RS2037839447 |
POLR3B
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism |
| RS2037842612 |
STAC3
|
Health Risk |
Pathogenic |
— |
| RS2037850257 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2037850716 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2037850990 |
ABCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2037853932 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2037865324 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2037884594 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2037906065 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS2037906616 |
POLR3B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2037908174 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Autism spectrum disorder |
| RS2037919953 |
GNAO1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS2037920339 |
GNAO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2037920369 |
GNAO1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2037920534 |
GNAO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS2037920694 |
GNAO1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Early-infantile DEE |
| RS2037920791 |
GNAO1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |